SCHEMBL4507482

SCHEMBL4507482

CCOc1ccc(S(=O)(=O)Nc2ccc(F)c(Cl)c2)c2c1C[C@@H](NC(=O)C(F)(F)F)CO2

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FABP4 P15090 1/20 0.42
THRB P10828 1/20 0.41
HPGD P15428 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
LMNA P02545 6/20 0.38
MEN1 O00255 4/20 0.38
KMT2A Q03164 4/20 0.38
ALDH1A1 P00352 3/20 0.38
NPSR1 Q6W5P4 3/20 0.38
PKM P14618 2/20 0.38
TSHR P16473 1/20 0.38
MAPT P10636 4/20 0.37
IDH1 O75874 2/20 0.37
EGFR P00533 2/20 0.37
ERBB2 P04626 1/20 0.37
PI4KB Q9UBF8 2/20 0.36
HTT P42858 3/20 0.35
KDM4E B2RXH2 1/20 0.35
GLA P06280 1/20 0.35
HSP90AA1 P07900 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4961539 0.91 THRB (0.48) FABP4THRBHPGDSMN1; SMN2LMNA
SCHEMBL4522619 0.89 IDH1 (0.39) FABP4THRBHPGDSMN1; SMN2LMNA
SCHEMBL4505898 0.85 MALT1 (0.41) THRBHPGDSMN1; SMN2LMNAMEN1
SCHEMBL4522968 0.82 IDH1 (0.40) LMNAMEN1KMT2AALDH1A1NPSR1
SCHEMBL13895395 0.82 THRB (0.48) FABP4THRBHPGDSMN1; SMN2LMNA
SCHEMBL4529640 0.81 TP53 (0.44) FABP4SMN1; SMN2NPSR1MAPTPI4KB
SCHEMBL4515375 0.77 HTR6 (0.49) LMNAMEN1KMT2AALDH1A1TSHR
SCHEMBL4523963 0.77 MEN1 (0.44) FABP4MEN1KMT2AALDH1A1PKM
SCHEMBL4512345 0.77 FABP4 (0.41) FABP4LMNAMEN1KMT2AALDH1A1
SCHEMBL4509184 0.77 THRB (0.50) FABP4THRBHPGDSMN1; SMN2LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090099187-A1 Novel 8-Sulfonyl-3 Aminosubstituted Chroman or Tetrahydronaphtalene Derivatives Modulating the 5HT6 Receptor ASTRAZENECA AB (SE) 2009-04-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090099187-A1 Novel 8-Sulfonyl-3 Aminosubstituted Chroman or Tetrahydronaphtalene Derivatives Modulating the 5HT6 Receptor HTR6, HTR1D, HTR1A FABP4 4575/4885THRB 485/4885HPGD 2286/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.